相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emergence of transferable ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae due to a novel CMY AmpC β-lactamase in China
Min Xu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Emergence of the New KPC-49 Variant Conferring an ESBL Phenotype with Resistance to Ceftazidime-Avibactam in the ST131-H30R1 Escherichia coli High-Risk Clone
Marta Hernandez-Garcia et al.
PATHOGENS (2021)
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae
Carolina Venditti et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature
Angela Cano et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Ceftazidime-Avibactam Resistance Associated with Increased blaKPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae
Marco Coppi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Different phenotypic expression of KPC β-lactamase variants and challenges in their detection
Saoussen Oueslati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Resistance to ceftazidime-avibactam and underlying mechanisms
Yuhang Wang et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background
Lingxiao Sun et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
Joshua L. C. Wong et al.
NATURE COMMUNICATIONS (2019)
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
Paolo Gaibani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae
Virginia M. Pierce et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2016)
The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3
Jesus Oteo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV beta-lactamases with single amino acid substitutions in the Omega-loop
Marisa L. Winkler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain
Lorena Lopez-Cerero et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Klebsiella pneumoniae ST258 Producing KPC-3 Identified in Italy Carries Novel Plasmids and OmpK36/OmpK35 Porin Variants
Aurora Garcia-Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
分享论文
